Day One Biopharmaceuticals, Inc.
DAWN
$21.31
$0.020.09%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 34.99% | 17.36% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 34.99% | 17.36% | |||
| Cost of Revenue | 35.74% | 18.99% | |||
| Gross Profit | 34.89% | 17.16% | |||
| SG&A Expenses | 21.32% | -2.83% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 26.75% | -7.02% | |||
| Operating Income | -13.22% | 30.66% | |||
| Income Before Tax | -17.89% | 34.94% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -7.87% | 34.94% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.87% | 34.94% | |||
| EBIT | -13.22% | 30.66% | |||
| EBITDA | -13.72% | 31.45% | |||
| EPS Basic | 0.00% | 35.15% | |||
| Normalized Basic EPS | -- | 35.13% | |||
| EPS Diluted | 0.00% | 35.15% | |||
| Normalized Diluted EPS | -- | 35.13% | |||
| Average Basic Shares Outstanding | -- | 0.30% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.30% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||